(RARE) Ultragenyx - Performance -36% in 12m
Compare RARE with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-43.00%
#60 in Group
Rel. Strength
23.36%
#6005 in Universe
Total Return 12m
-36.01%
#66 in Group
Total Return 5y
-38.78%
#54 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.24
35th Percentile in Group
FCF Yield -13.93%
38th Percentile in Group
12m Total Return: RARE (-36%) vs XBI (-19.1%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-7.66% | 23.1% | 204% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| AMGN NASDAQ Amgen |
-10.8% | 10.9% | 54.8% | 41 | 15 | 1.05 | -18.8% | -20% |
| HLN NYSE Haleon |
-11.3% | 13.4% | 27.4% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| LONN SW Lonza |
-14.3% | -12.5% | 25.1% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-4.51% | 13.6% | 11.8% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-18.9% | 10.8% | -6.86% | 27 | 25 | 1 | 58.7% | 15% |
| ERF PA Eurofins Scientific SE |
-10.4% | -21.6% | 2.79% | 23.9 | 12.7 | 0.58 | -70.8% | -17.1% |
| GRFS NASDAQ Grifols |
-22.3% | -10.2% | -65.6% | 35 | 12.1 | 0.23 | -76.8% | -8.79% |
Performance Comparison: RARE vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RARE
| Total Return (including Dividends) | RARE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -16.78% | -16.39% | -12.16% |
| 3 Months | -27.68% | -21.40% | -14.06% |
| 12 Months | -36.01% | -19.14% | -1.53% |
| 5 Years | -38.78% | -12.16% | 94.99% |
| Trend Score (consistency of price movement) | RARE | XBI | S&P 500 |
| 1 Month | -70.5% | -74% | -10.4% |
| 3 Months | -74.1% | -75.5% | -68.4% |
| 12 Months | -13.2% | -11.9% | 78.6% |
| 5 Years | -74.6% | -51% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #80 | -0.47% | -5.26% |
| 3 Month | #73 | -7.98% | -15.9% |
| 12 Month | #66 | -20.9% | -35.0% |
| 5 Years | #57 | -30.3% | -68.6% |
FAQs
Does RARE Ultragenyx outperforms the market?
No,
over the last 12 months RARE made -36.01%, while its related Sector, the SPDR S&P Biotech (XBI) made -19.14%.
Over the last 3 months RARE made -27.68%, while XBI made -21.40%.
Over the last 3 months RARE made -27.68%, while XBI made -21.40%.
Performance Comparison RARE vs Indeces and Sectors
RARE vs. Indices RARE is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.41% | -4.62% | -28.1% | -34.5% |
| US NASDAQ 100 | QQQ | -1.59% | -3.06% | -26.9% | -32.8% |
| US Dow Jones Industrial 30 | DIA | -1.64% | -5.58% | -29.9% | -35.1% |
| German DAX 40 | DAX | -0.58% | -2.87% | -42.3% | -43.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.54% | -3.50% | -5.58% | -33.8% |
| Hongkong Hang Seng | HSI | -0.79% | -2.42% | -17.3% | -40.9% |
| India NIFTY 50 | INDA | -6.68% | -16.9% | -27.0% | -30.5% |
| Brasil Bovespa | EWZ | -3.89% | -13.3% | -24.5% | -15.6% |
RARE vs. Sectors RARE is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.81% | -4.14% | -36.7% | -43.0% |
| Consumer Discretionary | XLY | -2.72% | -4.85% | -31.7% | -37.0% |
| Consumer Staples | XLP | -6.20% | -10.9% | -36.1% | -43.2% |
| Energy | XLE | 5.03% | -6.98% | -23.7% | -18.9% |
| Financial | XLF | 0.24% | -6.87% | -37.3% | -43.3% |
| Health Care | XLV | -3.34% | -7.21% | -28.5% | -31.7% |
| Industrial | XLI | -0.80% | -4.49% | -26.2% | -31.0% |
| Materials | XLB | -0.37% | -4.45% | -20.3% | -20.2% |
| Real Estate | XLRE | -2.09% | -6.87% | -28.2% | -37.6% |
| Technology | XLK | -0.09% | -0.88% | -21.0% | -25.6% |
| Utilities | XLU | -4.32% | -12.4% | -32.5% | -51.3% |
| Aerospace & Defense | XAR | -2.10% | -7.59% | -31.0% | -42.5% |
| Biotech | XBI | -1.24% | -0.39% | -14.5% | -16.9% |
| Homebuilder | XHB | -4.11% | -5.39% | -13.2% | -19.6% |
| Retail | XRT | -4.64% | -6.97% | -25.2% | -23.7% |